GeoYoung Surpasses 10,000 Deliveries of AstraZeneca Clinical Pharmaceuticals
Domestic pharmaceutical distribution company GeoYoung announced on the 20th that the delivery of clinical trial drugs for the global pharmaceutical company AstraZeneca, which began in October last year, has surpassed 10,000 units.
The clinical trial drug delivery business requires strict handling and management capabilities for clinical trial drugs, making it one of the most challenging specialized fields in pharmaceutical distribution.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump Puts Iran Strike on Hold One Day Before Attack... "Full-Scale Offensive If Talks Fail"
- At 24°C It's Iced Coffee, at 31°C Tube Ice Cream... "It's Only May" But Convenience Stores Already Know: The 'Summer Boom' Thermometer
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
GeoYoung Chairman Chosunhye said, “Clinical research science ensures patient safety by scientifically proving the efficacy and safety of drugs, and advances medical technology by developing new treatments,” adding, “We will focus the company’s logistics capabilities to ensure the smooth delivery of clinical trial drugs, which enable the diagnosis and treatment of diseases, protect human health, and improve quality of life.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
